Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$9.31 -0.08 (-0.85%)
At close: Nov 11, 2026 · 4:00 PM EST

Arcturus Therapeutics Holdings (ARCT) Return on Capital Employed [ROCE] (2019 - 2026)

Updated

Arcturus Therapeutics Holdings' Return on Capital Employed [ROCE] was -50.81% in Q2 2026, down 24.33 percentage points from -26.49% a year earlier and down 11.35 percentage points from the prior quarter.

Analysis

Arcturus Therapeutics Holdings (ARCT) Return on Capital Employed [ROCE] (2019 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Arcturus Therapeutics Holdings came in at -28.12%, up 1.66 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a five-year change of +3.01 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -29.78% in FY2024 (-7.93 pp), -21.85% in FY2023 (-25.98 pp), 4.13% in FY2022 (+64.67 pp) and -60.54% in FY2021 (-29.41 pp).
  • The Q2 2026 figure marks the lowest quarterly Return on Capital Employed [ROCE] since Q3 2022.
  • Compared with a year earlier, Return on Capital Employed [ROCE] was higher in three of the last eight quarters, with an average year-over-year change of -9.85 percentage points.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q1 2023 (a gain of 96.06 percentage points); the worst was Q1 2024 (a drop of 60.83 percentage points).
  • Per Business Quant data, ARCT's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -39.46% (Q1 2026), -31.73% (Q4 2025) and -29.67% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Arcturus Therapeutics Holdings 267.25 Mn -551.34 Mn - -49.60%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -49.60%
Jun 30, 2026 -50.81%
Mar 31, 2026 -39.46%
Dec 31, 2025 -31.73%
Sep 30, 2025 -29.67%
Jun 30, 2025 -26.49%
Mar 31, 2025 -28.45%
Dec 31, 2024 -32.78%
Sep 30, 2024 -25.97%
Jun 30, 2024 -28.56%
Mar 31, 2024 -39.97%
Dec 31, 2023 -21.63%
Sep 30, 2023 17.26%
Jun 30, 2023 12.22%
Mar 31, 2023 20.87%
Dec 31, 2022 4.97%
Sep 30, 2022 -61.35%
Jun 30, 2022 -66.44%
Mar 31, 2022 -75.19%
Dec 31, 2021 -64.57%
API Access

Arcturus Therapeutics Holdings Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ARCT&period=max&api_key=YOUR_API_KEY